Since founding Rational Therapeutics (now Nagourney Cancer Institute) over 20 years ago, Dr. Nagourney, his team and colleagues have published a number of papers supporting the use of the Ex-Vivo Analysis of Programmed Cell Death (EVA-PCD) functional profiling assay, general cancer research, and the effectiveness of new drugs and combinations.
Dr. Nagourney himself has AUTHORED more than 100 manuscripts, book chapters and abstracts including publications in the JOURNAL OF CLINICAL ONCOLOGY, GYNECOLOGIC ONCOLOGY, THE JOURNAL OF THE NATIONAL CANCER INSTITUTE. and BRITISH JOURNAL OF CANCER.
We have selected a few of our most prominent papers to make available for download on this site.
* NEW* Our exciting latest paper just released August 2018 reported that it was possible to identify who would develop breast cancer with >95% accuracy from looking at only a drop of blood. It was an international study of over 1,200 patients looking at over almost 200 chemicals in the blood stream and finding differences between “normal” patients and those that developed breast cancer.
This means that it may be possible to predict who is on the way to getting breast cancer and could suggest ways to make diet and lifestyle changes to prevent ever getting breast cancer.